» Articles » PMID: 7504167

Physostigmine Block of Ion Channels Activated by Acetylcholine in BC3H1 Cells

Overview
Journal Mol Pharmacol
Date 1993 Nov 1
PMID 7504167
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Single-channel recording techniques have been used to study the effects of physostigmine on the kinetics of ion channels activated by acetylcholine in BC3H1 mouse tumor cells grown in culture. Physostigmine reduced mean channel open time, with 50% reduction occurring at about 7 microM physostigmine. Although openings did not appear to occur in bursts, channel closed-time distributions exhibited a new component 7-8 msec in duration. The area of this component, but not its time constant, increased with higher concentrations of physostigmine. Results are consistent with a simple sequential channel-blocking model in which the new closed-time component represents a blocked state of the channel. Membrane hyperpolarization increased the potency of physostigmine in reducing channel open time and also prolonged the duration of the blocked state. The voltage dependence of physostigmine block was unexpected, because physostigmine is uncharged at physiological pH.

Citing Articles

The E Loop of the Transmitter Binding Site Is a Key Determinant of the Modulatory Effects of Physostigmine on Neuronal Nicotinic α4β2 Receptors.

Jin X, McCollum M, Germann A, Akk G, Steinbach J Mol Pharmacol. 2016; 91(2):100-109.

PMID: 27895161 PMC: 5267520. DOI: 10.1124/mol.116.106484.


Activation and block of the adult muscle-type nicotinic receptor by physostigmine: single-channel studies.

Militante J, Ma B, Akk G, Steinbach J Mol Pharmacol. 2008; 74(3):764-76.

PMID: 18523135 PMC: 2536770. DOI: 10.1124/mol.108.047134.


Diverse inhibitory actions of quaternary ammonium cholinesterase inhibitors on Torpedo nicotinic ACh receptors transplanted to Xenopus oocytes.

Olivera-Bravo S, Ivorra I, Morales A Br J Pharmacol. 2007; 151(8):1280-92.

PMID: 17572698 PMC: 2189822. DOI: 10.1038/sj.bjp.0707329.


Galantamine activates muscle-type nicotinic acetylcholine receptors without binding to the acetylcholine-binding site.

Akk G, Steinbach J J Neurosci. 2005; 25(8):1992-2001.

PMID: 15728839 PMC: 6726061. DOI: 10.1523/JNEUROSCI.4985-04.2005.


The acetylcholinesterase inhibitor BW284c51 is a potent blocker of Torpedo nicotinic AchRs incorporated into the Xenopus oocyte membrane.

Olivera-Bravo S, Ivorra I, Morales A Br J Pharmacol. 2005; 144(1):88-97.

PMID: 15644872 PMC: 1575971. DOI: 10.1038/sj.bjp.0705965.